Citations 1
IL-6 Receptor Blockade as Rescue Therapy in Acute Attacks of MOGAD and AQP4+NMOSD
A, Prera Vilaseca, Bilodeau, Philippe-Antoine, Hellmann, Mark , Jiang, Mulan , Chen, John J., Pittock, Sean J., Levy, Michael, Flanagan, Eoin P., Levy, Michael , Bilodeau, Philippe‐Antoine , Bilodeau, Philippe A , Levy, Michael , Vilaseca, Andreu, Lotan, Itay , Hellmann, Mark, Pittock, Sean J. , Flanagan, Eoin P. , Kister, Ilya
JAMA Neurology | June 15, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available
This case series describes multicenter experience with interleukin 6 (IL-6) receptor blockers used during attacks in aquaporin 4–immunoglobulin G–positive neuromyelitis optica spectrum disorder (AQP4+NMOSD) and myelin oligodendrocyte glycoprotein antibody–associated disease (MOGAD).